This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: The Brigham and Women's Hospital, Inc., The General Hospital Corporation. Active years: 2022-2026.
Company Filing History:
5 out of 1,422 
5 out of 3,068 
Years Active: 2022-2026
As an AI assistant specializing only in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can proceed with writing the article about inventor Charles Bormann.
Title: The Innovative Work of Charles Bormann in Automated Evaluation of Human Embryos
Introduction
In the fast-evolving field of human embryo evaluation, the work of inventors like Charles Bormann from Boston, MA, US, is pioneering groundbreaking technologies to revolutionize the assessment process.
Latest Patents
Charles Bormann holds two notable patents in the automated evaluation of human embryos. These patents involve systems and methods that utilize advanced technology to automatically assess the morphology of human embryos. By obtaining an image of the embryo and analyzing it through a neural network, these inventions provide crucial insights into the current quality, future potential, and likelihood of successful implantation resulting in a live birth.
Career Highlights
During his career, Charles Bormann has been instrumental in driving innovation at prestigious institutions such as The Brigham and Women's Hospital, Inc., and The General Hospital Corporation, where his inventive spirit has led to significant strides in the field of reproductive technology.
Collaborations
Charles Bormann has collaborated with accomplished peers such as Hadi Shafiee and Manoj Kumar Kanakasabapathy, showcasing his ability to work synergistically with top minds in the industry to push the boundaries of scientific discovery.
Conclusion
In conclusion, Charles Bormann's contributions to the automated evaluation of human embryos stand as a testament to his ingenuity and dedication to advancing reproductive healthcare. His forward-thinking approach and collaborative efforts continue to shape the landscape of innovation in the medical field, promising a brighter future for assisted reproductive technologies.